Features
The First CRISPR Treatment: Changing the Fate of Sickle Cell Disease
For decades, sickle cell disease has been treated as a condition to manage rather than one that could be changed at its source, with no known cure on the horizon until recently. Globally, sickle cell disease affects about 8 million people, and in the United States, about 100,000 people